Profile Picture
  • All
  • Search
  • Images
  • Videos
    • Shorts
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
Report an inappropriate content
Please select one of the options below.

Top suggestions for gilteritinib

Nct02317939
Nct02317939
Relapsed AML
Relapsed
AML
Eunice Wang
Eunice
Wang
AML Interview
AML
Interview
Dr. Altman
Dr.
Altman
Tt0323917
Tt0323917
Efsitora Qwint Trials
Efsitora Qwint
Trials
Sorafenib
Sorafenib
Mutated AML
Mutated
AML
World Trials Exeter RI 2025
World Trials Exeter
RI 2025
Mark Levi's
Mark
Levi's
FLT3 Mutation
FLT3
Mutation
Redner
Redner
Astellas Pharma
Astellas
Pharma
Do NSG Mice Have Intact FLT3 Ligand
Do NSG Mice Have
Intact FLT3 Ligand
TCancer
TCancer
Dr. Patel
Dr.
Patel
Alexander Perls
Alexander
Perls
Almnatiq
Almnatiq
Daniel DeAngelo
Daniel
DeAngelo
Quizartinib
Quizartinib
Keith Pratz
Keith
Pratz
Acute Myeloid Leukemia
Acute Myeloid
Leukemia
Mlay Liser T3
Mlay Liser
T3
Dr DeAngelo
Dr
DeAngelo
Acute Myeloid Cancer
Acute Myeloid
Cancer
Alex Pearl
Alex
Pearl
Monotherapy
Monotherapy
Gobind Rai Garg
Gobind Rai
Garg
FLT3 AML
FLT3
AML
Refractory
Refractory
Waddell Pronunciation
Waddell
Pronunciation
Mutant Phase
Mutant
Phase
Mark Levi
Mark
Levi
Dr Gobind Rai Garg
Dr Gobind
Rai Garg
Acute Myeloid Leukemia Summary As
Acute Myeloid Leukemia
Summary As
Acute Myeloid Leukemia Survival Rate
Acute Myeloid Leukemia
Survival Rate
Interview AML
Interview
AML
Belmont Pronunciation
Belmont
Pronunciation
Demeter Pronunciation
Demeter
Pronunciation
Venetoclax AML
Venetoclax
AML
Resistance Mechanisms
Resistance
Mechanisms
Leopold Pronunciation
Leopold
Pronunciation
Dimethyltryptamine Pronounce
Dimethyltryptamine
Pronounce
Inhibitor Melbourne
Inhibitor
Melbourne
Acue Highlights
Acue
Highlights
Genetic Drug Resistance Mechanism
Genetic Drug Resistance
Mechanism
Donepezil Pronunciation
Donepezil
Pronunciation
Pronunciation of Continue
Pronunciation
of Continue
  • Length
    AllShort (less than 5 minutes)Medium (5-20 minutes)Long (more than 20 minutes)
  • Date
    AllPast 24 hoursPast weekPast monthPast year
  • Resolution
    AllLower than 360p360p or higher480p or higher720p or higher1080p or higher
  • Source
    All
    Dailymotion
    Vimeo
    Metacafe
    Hulu
    VEVO
    Myspace
    MTV
    CBS
    Fox
    CNN
    MSN
  • Price
    AllFreePaid
  • Clear filters
  • SafeSearch:
  • Moderate
    StrictModerate (default)Off
Filter
  1. Nct02317939
  2. Relapsed
    AML
  3. Eunice
    Wang
  4. AML
    Interview
  5. Dr.
    Altman
  6. Tt0323917
  7. Efsitora Qwint
    Trials
  8. Sorafenib
  9. Mutated
    AML
  10. World Trials Exeter
    RI 2025
  11. Mark
    Levi's
  12. FLT3
    Mutation
  13. Redner
  14. Astellas
    Pharma
  15. Do NSG Mice Have
    Intact FLT3 Ligand
  16. TCancer
  17. Dr.
    Patel
  18. Alexander
    Perls
  19. Almnatiq
  20. Daniel
    DeAngelo
  21. Quizartinib
  22. Keith
    Pratz
  23. Acute Myeloid
    Leukemia
  24. Mlay Liser
    T3
  25. Dr
    DeAngelo
  26. Acute Myeloid
    Cancer
  27. Alex
    Pearl
  28. Monotherapy
  29. Gobind Rai
    Garg
  30. FLT3
    AML
  31. Refractory
  32. Waddell
    Pronunciation
  33. Mutant
    Phase
  34. Mark
    Levi
  35. Dr Gobind
    Rai Garg
  36. Acute Myeloid Leukemia
    Summary As
  37. Acute Myeloid Leukemia
    Survival Rate
  38. Interview
    AML
  39. Belmont
    Pronunciation
  40. Demeter
    Pronunciation
  41. Venetoclax
    AML
  42. Resistance
    Mechanisms
  43. Leopold
    Pronunciation
  44. Dimethyltryptamine
    Pronounce
  45. Inhibitor
    Melbourne
  46. Acue
    Highlights
  47. Genetic Drug Resistance
    Mechanism
  48. Donepezil
    Pronunciation
  49. Pronunciation
    of Continue
Optimizing therapy and extending survival in AML: balancing efficacy and toxicity
1:46
Optimizing therapy and extending survival in AML: balancing efficac…
51 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Evidence for the use of gilteritinib as post-transplant maintenance in R/R AML
1:00
Evidence for the use of gilteritinib as post-transplant maintenance i…
24 views2 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Is gilteritinib the new breakthrough in the treatment of FLT3-mutated AML?
1:33
Is gilteritinib the new breakthrough in the treatment of FLT3-mutated …
480 viewsJul 25, 2017
YouTubeVJHemOnc – Video Journal of Hematology & H…
The all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with AML
2:18
The all-oral regimen of decitabine/cedazuridine, venetocl…
144 viewsJun 16, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Understanding the results of MORPHO: gilteritinib as post-transplant maintenance for FLT3-ITD AML
2:03
Understanding the results of MORPHO: gilteritinib as post-tran…
17 views1 week ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
Gilteritinib monotherapy vs combination therapy in R/R FLT3-mutated AML
1:43
Gilteritinib monotherapy vs combination therapy in R/R FLT3-…
198 viewsSep 11, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Key challenges in overcoming resistance to FLT3 inhibitors in AML
1:10
Key challenges in overcoming resistance to FLT3 inhibitors in AML
15 views2 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:15
Dr. Patel on the Role of Gilteritinib in FLT3+ AML
279 viewsFeb 17, 2020
YouTubeOncLive
2:39
The VICEROY study: VEN/AZA/GILT in newly diagnosed FLT3-mutated …
13 views1 week ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:41
Combining targeted agents with existing backbones to improve ou…
1 views4 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder
More like this
Feedback
  • Privacy
  • Terms